Hazardous Drug Sample Analysis

The Department of Health and Human Services is issuing a Request for Quotation (RFQ HT942726QE008) for Hazardous Drugs Sample Analysis (HDSA) services (Product Service Code Q301). Offerors must submit a complete, factual quotation that includes three volumes: (1) Technical Capability and Past Performance (Microsoft Word or searchable PDF), (2) Cost/Price (Microsoft Excel spreadsheet with a pricing narrative in Word or PDF), and (3) required FAR clauses (52.212‑1, ‑3, ‑4, ‑5). The quotation must demonstrate an approach that reduces cost, technical, or schedule risk, and must address the validation of the analytical process so that the electronic data deliverable (EDD) – a tab‑delimited text file – contains identical sample numbers, fields, and analytical results as the hard‑copy report. Offerors must also complete solicitation blocks 12, 17, 23, 24, and 30 and may qualify under the economically disadvantaged, women‑owned, service‑disabled veteran‑owned, HUBZone, or other small‑business categories. The solicitation uses a Best‑Value Tradeoff source‑selection process; technical and past‑performance ratings (Outstanding to Unacceptable) and past‑performance relevancy (Very Relevant to Somewhat Relevant) will be applied. Questions are due by 1:00 p.m. EST on 20 April 2026 (email jennifer.s.bassett.civ@health.mil); no questions will be accepted after that time. Quotations must be received electronically by 11:00 a.m. EST on 24 April 2026 and must include a minimum 30‑day offer‑acceptance period with firm pricing. The award is expected no later than 1 May 2026.

Notice ID

224f95e8d6ee4372b4fa1c17079db6c3

Solicitation Number

HT942726QE008

NAICS Code

541380

Classification Code

Q301